![](/img/cover-not-exists.png)
PRS7 ANALYSIS OF THE PREDICTIVE ABILITY OF DIAGNOSTIC COST GROUPS, RXGROUPS, AND PRIOR COST FORTEXAS MEDICAID COPD PATIENTS
SA Yarger, KL Rascati, RC LeslieVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65117-0
File:
PDF, 72 KB
english, 2007